サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Pharmaceutical Contract Manufacturing Market 2019-2029

医薬品製造受託市場2019−2029

レポート概要

医薬品製造受託市場は予測期間の前半に5.7%の年平均成長率(CAGR)で拡大すると予想されます。2018年にはAPI製造のサブマーケットが67%を占めました。Vitiongainの推定によると、医薬品製造受託市場は2024年に1,380億ドルに達する見込みです。

このレポートがもたらすメリット

読み進めるにつれて将来このセクターに出現するビジネスチャンスをどのようにして掴むことかできるか、その方法が明らかになります。

ここには73の表と55のグラフを掲載 ‐ これらは全て他のどこからも入手できないものです。

この231ページのレポートは世界の医薬品製造受託市場について明確で詳細な見識を与えます。さらに、市場に影響を及ぼす主な推進要因と課題を示します。

読み進めるにつれてこのセクターに出現するビジネスチャンスを掴む方法が明らかになります。

この212ページのレポートに121の表とグラフを掲載‐これらは全て他のどこでも入手できないものです。

このレポートを利用することによってについて明確で詳細な見識を得ることができます。また市場の主な推進要因と課題が明らかになります。

レポート詳細

目次

1. Report Overview
1.1 Global Pharmaceutical Contract Manufacturing Market Segmentation
1.2 Global Pharmaceutical Contract Manufacturing Market Overview
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2. Introduction to Pharmaceutical Contract Manufacturing
2.1 What is Pharmaceutical Contract Manufacturing?
2.2 The Benefits of Outsourcing in the Pharmaceutical Market
2.3 Pharmaceutical Contract Manufacturing Services
2.4 Strategy and Tactics: The Importance of Outsourcing Wisely
2.5 Trends in Contract Manufacturing, 2018-2029
2.6 Pharmaceutical Contract Manufacturing: Market Segmentation

3. Pharmaceutical Contract Manufacturing: World Market 2019-2029
3.1 Pharmaceutical Contract Manufacturing Market:
3.1.1 Contract Manufacturing is the Most Mature Pharma Outsourcing Sector
3.1.2 The Pharma Contract Manufacturing Market by Sector 2018
3.2 Pharma Contract Manufacturing: Overall Market Forecast 2019-2029
3.2.1 Changing Market Shares by Segment 2018-2029
3.2.2 Drivers for Growth in the Contract Manufacturing Market to 2029
3.2.3 Generics: A Driver or Restraint?
3.2.4 Other Contract Manufacturing Services Market: Outlook and Forecast, 2019-2029
3.2.4.1 Increasing Demand for Formulation Development Services

4. The Contract API Manufacturing Services Submarket 2019-2029
4.1 The Contract API Manufacturing Submarket
4.1.1 Chemical APIs Will Experience Resurgence after the Shift of Focus to Biological APIs
4.1.2 The API Manufacturing Submarket by Sector, 2018
4.2 The Contract API Manufacturing Submarket: Outlook and Forecast 2019-2029
4.2.1 Drivers for Growth in the API Submarket to 2029
4.2.2 The Potential for Microreactors in Commercial Manufacturing to 2029
4.2.3 How Will New EU Regulations Impact the API Manufacturing Submarket?
4.2.4 Contract API Manufacturing Submarket Restraint 2019-2029
4.2.4.1 Backwards Integration for Generics Manufacturers
4.3 The Contract Generic API Manufacturing Submarket 2019-2029
4.3.1 The Contract Generic API Manufacturing Submarket Forecast 2019-2029
4.3.2 The Contract Generic API Manufacturing Submarket Drivers and Restraints to 2029
4.3.2.1 The US Generic Drug User Fee Act and API Manufacturing
4.4 The Contract HPAPI Manufacturing Submarket 2015-2028
4.4.1 Challenges and Opportunities in High Containment Manufacturing
4.4.2 Company Investment into HPAPI Manufacturing Facilities: Growth Increases in the HPAPI Manufacturing Sector
4.4.3 The Contract HPAPI Manufacturing Submarket Forecast 2018-2029
4.4.4 The Contract HPAPI Manufacturing Submarket Drivers and Restraints to 2029

5. The Contract FDF Manufacturing Services Submarket 2019-2029
5.1 The Contract FDF Manufacturing Submarket, 2018
5.1.1 Solid Dosage Manufacturing Leads the Market
5.1.2 CMOs Report High Demand for Softgel Formulations
5.2 The Contract FDF Manufacturing Submarket Forecast 2019-2029
5.2.1 Complex Molecule Manufacturing Will Drive Growth to 2029
5.2.2 What Will Restrain Growth in FDF Outsourcing?
5.3 The Contract Solid Dosage Manufacturing Submarket 2019-2029
5.3.1 How Will Revenue for Solid Dosage Manufacturing Grow to 2029?
5.3.2 The Solid Dosage Manufacturing Submarket Drivers and Restraints 2019-2029
5.3.2.1 Will Product Reformulation Drive Growth to 2029?
5.4 The Contract Injectable Dosage Manufacturing Submarket 2019-2029
5.4.1 The Contract Injectable Dosage Manufacturing Submarket Forecast 2019-2029
5.4.1.1 Drug Shortages Offer Opportunity to CMOs in the Short-Term
5.4.2 Demand for Biopharma Manufacturing Will Drive Growth 2019-2029
5.4.2.1 Interest in Antibody-Drug Conjugate Development Is Growing
5.4.2.3 Challenges in Manufacturing Antibody-Drug Conjugates
5.4.3 Lyophilisation and Aseptic Filling Demand Will Rise
5.4.3.1 Will Spray Drying Replace Lyophilisation in FDF Manufacturing?

6. Leading National Markets for Pharmaceutical Contract Manufacturing 2019-2029
6.1 Leading National Markets for Pharmaceutical Contract Manufacturing, 2018
6.1.1 Challenges in Assessing the Market: Supply versus Demand
6.1.2 Leading National Pharmaceutical Contract Manufacturing Markets: Revenue Forecasts 2019-2029
6.1.3 Pharmaceutical Manufacturing in the US: Regulatory Oversight, 2018
6.1.4 Controlling Foreign Manufacturing Sites
6.1.5 What Impact Will the GDUFA 2012 Have on Foreign Manufacturing?
6.1.6 Outsourcing and US Manufacturing Regulations
6.1.7 Increased Demand for Domestic API Manufacturing?
6.2 The US Contract Manufacturing Market Forecast 2019-2029
6.3 Canada Contract Manufacturing Market Forecast 2019-2029
6.4 Outlook for Pharmaceutical Contract Manufacturing in the EU
6.4.1 The EU is the Leading Destination for Pharmaceutical Contract Manufacturing
6.4.2 Regulatory Aspects of Pharma Manufacturing in the EU
6.4.2.1 The European Commission Amends Annex
6.4.2.2 The Falsified Medicine Directive: Controlling API Imports
6.4.3 Biopharma Manufacturing Demand Will Rise
6.4.4 The EU Contract Manufacturing Market Forecast 2019-2029
6.4.5 Germany: The Leading EU Destination for API and FDF Manufacturing
6.4.5.1 Demand for Contract Manufacturing in Germany: Revenue Forecast 2019-2029
6.4.6 CMOs Account for a Third of Manufacturing Sites in France
6.4.6.1 French Pharma Contract Manufacturing Market Forecast 2019-2029
6.4.7 Italy: Strong API Manufacturing Traditions
6.4.7.1 Revenue Forecast for the Italian Pharma Contract Manufacturing Market 2019-2029
6.4.8 Spain: How Will Demand for Manufacturing Services Grow?
6.4.9 UK: Pharmaceutical Contract Manufacturing Market Forecast 2019-2029
6.5 Pharma Contract Manufacturing in Japan to 2029
6.5.1 Pharmaceutical Manufacturing Regulations in Japan
6.5.1.1 The Pharmaceutical Affairs Law
6.5.2 Greater API Outsourcing to Drive Japanese Market Growth to 2028 In Spite of Currency Devaluation Weakening the Economy

7. Leading Emerging Markets for Pharmaceutical Contract Manufacturing Market 2019-2029
7.1 Pharmaceutical Contract Manufacturing in Developing Countries
7.1.1 Outsourcing to Emerging National Markets from Developed Markets
7.1.1.1 Demand Will Increase for Services in India and China
7.1.2 Domestic Demand for Pharmaceutical Contract Manufacturing Services
7.1.3 Pharmaceutical Contract Manufacturing: Leading Emerging National Market Forecasts 2019-2029
7.2 Chinese Demand for Pharma Contract Manufacturing Services 2019-2029
7.2.1 Improved Manufacturing Regulations in China
7.2.1.1 Regulations for Excipients and Guidance for API Manufacturing
7.2.1.2 What Are the Consequences to Stricter Manufacturing Regulations in China?
7.2.2 Chinese CMOs Are Investing in Biopharma Manufacturing
7.2.3 China Pharma Contract Manufacturing Market Forecast 2019-2029
7.3 India: CMOs with Strong Infrastructure and Growing Expertise
7.3.1 Regulatory Outlook for Indian Pharma Manufacturing
7.3.1.1 Stricter Quality Standards to Ensure Compliance with EU Rules
7.3.2 Domestic Manufacturing Dominates the Indian Pharma Market
7.3.3 Demand for Contract Manufacturing in India: Market Forecast 2019-2029
7.4 Brazil: Contract Manufacturing Outlook 2019-2029
7.4.1 Pharmaceutical Manufacturing Regulations in Brazil
7.4.1.1 Guidelines and Regulations Proposed
7.4.2 Brazil Imports Most of its APIs
7.4.3 Brazil: Pharma Contract Manufacturing Market Forecast 2019-2029
7.5 The Russian Pharma Contract Manufacturing Market 2019-2029
7.5.1 Pharma Manufacturing Regulations in Russia
7.5.1.1 Compliance with GMP in Russia
7.5.2 How Will Demand for Contract Manufacturing Grow in Russia to 2029?
7.6 South Korea: Government Supported Growth
7.6.1 South Korea: Strict GMP Regulations
7.6.2 South Korea: Pharma Contract Manufacturing Market Forecast 2019-2029
7.7 Turkey: Domestic Market to offer Huge Growth Opportunities
7.7.1 Turkey: An Important Hub for Global Pharma Companies
7.7.2 Drug Approvals Delaying Growth of the Turkey Pharma Market
7.7.3 Turkey: Pharma Contract Manufacturing Market Forecast 2019-2029
7.8 Mexico: Emerging Market Power
7.8.1 Healthcare - A Top Priority in Mexico
7.8.2 Strategic Management of High Expectations
7.8.3 Mexico: Pharma Contract Manufacturing Market Forecast 2019-2029

8. Leading Companies in the Pharmaceutical Contract Manufacturing Market
8.1 Leading CMOs in the Pharmaceutical Contract Manufacturing Market
8.2 Catalent: Leading CMO
8.2.1 Multiple Expansions and Increased Focus on Biologic Manufacturing
8.2.2 Recent Developments
8.3 Lonza: Potential to Lead in ADC Manufacturing
8.3.1 Lonza: Expanding its Capacities to Meet Customer Demand for Biologic Manufacturing
8.3.2 Recent Developments
8.4 Evonik Degussa: Specialising in Small Molecules
8.4.1 Recent Developments
8.5 DPx Holdings - DSM and Patheon: Recent Merger Has Strengthened Their Position
8.5.1 Increasing Capacity Tactically and Expanding Worldwide
8.6 Teva: The World’s Largest API Manufacturer
8.6.1 Will Teva Expand into Emerging Markets?
8.6.2 Recent Developments
8.7 Boehringer Ingelheim BioXcellence: Boehringer’s Biopharma Manufacturing Division
8.7.1 Recent Developments
8.7.2 Adding New Services for Growth
8.8 Famar: A Possible Candidate for Acquisition
8.8.1 Recent Developments
8.9 Fareva: A Strategic Shift from Acquisition to Increase in Capacity
8.10 Vetter Pharma: Specialists in Aseptic Filling, Lyophilisation and Siliconisation
8.10.1 Vetter’s Growth: Increasing in Capacity and Market Expansion
8.11 Mylan: A World Leader in Generics Manufacturing
8.11.1 Recent Developments

9. Pharmaceutical Contract Manufacturing Industry Trends: Qualitative Analysis from a CMO Perspective 2019-2029
9.1 Pharma Contract Manufacturing Market: Strengths and Weaknesses from a CMO Perspective 2019-2029
9.2 Pharma Contract Manufacturing Market: Opportunities and Threats from a CMO Perspective 2019-2029
9.3 Pharma Contract Manufacturing Market: STEP Analysis 2019-2029
9.3.1 Social Factors
9.3.2 New Technologies Will Drive Market Growth to 2029
9.3.2.1 Advantages of Single-Use Technologies in Biopharma Manufacturing
9.3.2.2 Green Technology in Contract Manufacturing
9.3.2.3 Drug Delivery Trends and CMOs
9.3.2.4 Biologics Are Causing Increased Demand for Lyophilisation
9.3.2.5 Improving Solubility and Stability for Small Molecules
9.3.2.6 Spray Drying as an Advantageous Alternative to Lyophilisation
9.3.2.7 Hot-Melt Extrusion: A Niche Opportunity
9.3.3 Economic Pressures
9.3.3.1 Developed-Market CMOs Facing Competition from Emerging Markets
9.3.4 Political Issues
9.3.4.1 How Will Regulatory Developments Affect CMOs?
9.4 Trends in Drug Development Affecting CMOs to 2028
9.4.1 Orphan Drug Development: Smaller Manufacturing Capacities
9.4.2 Complex Biologics: Interest in ADCs is increasing
9.4.3 How Will Biosimilar Market Growth Affect CMOs?
9.4.4 The Future of Small Molecule Outsourcing
9.5 How Will CMOs Expand in the Coming 10 Years?
9.5.1 CMO Consolidation Will Increase
9.5.2 There Will Be More Manufacturing Facilities Available for Acquisition
9.6 Developments in the Manufacturing Process
9.6.1 Rising Interest from Companies in Quality by Design (QbD)
9.6.2 A Move Towards Continuous Manufacturing

10. Pharmaceutical Contract Manufacturing Trends: Qualitative Analysis of the Pharmaceutical Contract Manufacturing Market from a Client Perspective 2019-2029
10.1 Pharma Contract Manufacturing Market: Strengths and Weaknesses from a Client Perspective 2019-2029
10.2 Pharma Contract Manufacturing Market: Opportunities and Threats from a Client Perspective 2019-2029
10.3 Important Aspects of the Outsourcing Decision
10.3.1 What Factors Will Influence CMO Selection?
10.3.2 CMO - Pharma Partnering Models
10.3.3 Strategic Partnering
10.3.4 Selecting a Local CMO vs. Offshoring
10.3.5 CMOs in Emerging Markets
10.3.6 Good Communication is Vital for Success
10.3.7 Ensuring Protection in Intellectual Property and Tech Transfer
10.3.8 Regulatory Compliance is a Key Deciding Factor for Pharma Clients
10.3.8.1 Regulatory Bodies and Outsourcing
10.3.8.2 Quality Agreement
10.3.8.3 Global Harmonisation Will Improve Compliance
10.4 Trends in Outsourcing Partnerships 2019-2029
10.4.1 Big Pharma and Outsourced Manufacturing
10.4.2 Small and Virtual Pharma Companies
10.4.3 How Will Biotech Funding Impact the Pharma Contract Manufacturing Industry to 2029?

11. Conclusions
11.1 The World Pharmaceutical Contract Manufacturing Market
11.2 Outlook for the Market to 2029
11.2.1 Rising Demand for High Value Services 2018-2029
11.2.2 Demand Will Be Highest Among Developed-Market Clients
11.3 Which New Technologies Will Stimulate Demand to 2029?

Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain report evaluation form

List of Tables
Table 3.1 Pharma Contract Manufacturing Market: Revenue ($bn) and Market Share (%) by Sector, 2018
Table 3.2 Pharmaceutical Contract Manufacturing Market: Overall Market Forecasts by Sector, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029
Table 3.3 Pharma Contract Manufacturing Market: Market Shares (%), 2018-2023
Table 3.4 Pharma Contract Manufacturing Market: Market Shares (%), 2024-2029
Table 3.5 Other Services Submarket Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2018-2029
Table 4.1 Contract API Manufacturing Submarket: Revenue ($bn) and Submarket Share (%) by Sector, 2018
Table 4.2 Contract API Manufacturing Submarket: Overall Submarket Forecasts by Sector, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029
Table 4.3 Contract API Manufacturing Submarket Shares (%), 2018-2023
Table 4.4 Contract API Manufacturing Submarket Shares (%), 2023-2029
Table 4.5 Contract API Manufacturing Submarket: Drivers and Restraints, 2018-2029
Table 4.6 Contract Generic API Manufacturing Submarket Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029
Table 4.7 Contract Generic API Manufacturing Submarket: Drivers and Restraints, 2019-2029
Table 4.8 Contract HPAPI Manufacturing Submarket Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029
Table 4.9 Contract HPAPI Manufacturing Submarket: Drivers and Restraints, 2019-2029
Table 5.1 Contract FDF Manufacturing Submarket: Revenue ($bn) and Submarket Share (%) by Sector, 2018
Table 5.2 Contract FDF Manufacturing Submarket: Overall Submarket Forecasts by Sector, Revenue ($bn), Annual Growth (%), CAGR (%), 2018-2029
Table 5.3 Contract FDF Manufacturing Submarket: Segment Shares (%), 2018-2023
Table 5.4 Contract FDF Manufacturing Submarket: Segment Shares (%), 2023-2029
Table 5.5 Contract FDF Manufacturing Submarket: Drivers and Restraints, 2019-2029
Table 5.6 Contract Solid Dosage Manufacturing Submarket Forecast, Revenue ($bn), Annual Growth (%), CAGR (%) 2019-2029
Table 5.7 Contract Solid Dosage Manufacturing Submarket: Drivers and Restraints, 2018-2029
Table 5.8 Contract Injectable Dosage Manufacturing Submarket Forecast, Revenue ($bn), Annual Growth (%), CAGR (%) 2019-2029
Table 5.9 Contract Injectable Dosage Manufacturing Submarket: Drivers and Restraints, 2019-2029
Table 5.10 Selected ADCs in Development, 2018
Table 5.11 Selected CMOs Investing in ADC Manufacturing Capacity, 2018
Table 6.1 Pharma Contract Manufacturing Market: Revenues ($bn) and Market Shares (%) by Region, 2018
Table 6.2 Pharma Contract Manufacturing Market: Regional Forecasts, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029
Table 6.3 Pharmaceutical Contract Manufacturing Market: Submarket Shares (%), 2018-2023
Table 6.4 Pharmaceutical Contract Manufacturing Market: Submarket Shares (%), 2023-2029
Table 6.5 GDUFA: Annual Fees for Domestic and Foreign Manufacturing Sites, 2015-2016
Table 6.6 US Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2018-2029
Table 6.7 Canada Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2018-2029
Table 6.8 EU Pharma Contract Manufacturing Market: Revenue ($bn) and Market Share (%) by Leading Country, 2018
Table 6.9 EU Pharma Contract Manufacturing Market: Revenue ($bn) and Market Share (%) by Leading Country, 2023
Table 6.10 EU Pharma Contract Manufacturing Market: Revenue ($bn) and Market Share (%) by Leading Country, 2029
Table 6.11 EU5 Pharma Contract Manufacturing Market: National Market Forecasts, Revenue ($bn), Annual Growth (%), CAGR (%), 2018-2029
Table 6.12 German Pharma Contract Manufacturing: Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2018-2029
Table 6.13 Selected French Manufacturing Site Acquisitions, 2009-2013
Table 6.14 French Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029
Table 6.15 Italian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029
Table 6.16 Spanish Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029
Table 6.17 UK Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029
Table 6.18 Japanese Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029
Table 7.1 Pharma Contract Manufacturing Market: Emerging Market Revenue ($bn) and Market Share (%) by Top Country, 2018
Table 7.2 Pharma Contract Manufacturing Market: Leading Emerging Market Forecasts ($bn), Annual Growth (%), CAGR (%), 2018-2029
Table 7.3 Pharma Contract Manufacturing Market: Emerging Market Shares (%), 2018-2023
Table 7.4 Pharma Contract Manufacturing Market: Emerging Market Shares (%), 2023-2029
Table 7.5 Chinese Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029
Table 7.6 Indian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029
Table 7.7 Brazilian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029
Table 7.8 Russian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029
Table 7.9 South Korean Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029
Table 7.10 Turkey Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029
Table 7.11 Mexico Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2019-2029
Table 8.1 Catalent: Revenue ($bn), Annual Growth, CAGR, 2013-2018
Table 8.2 Lonza: Revenue (CHF bn), Annual Growth (%), CAGR (%), 2013-2018
Table 8.3 Teva: Revenue ($bn), Annual Growth (%), CAGR (%), 2012-2017
Table 8.4 Boehringer Ingelheim BioXcellence: Revenue (CHF bn), Annual Growth (%), CAGR (%), 2012-2017
Table 9.1 Pharma Contract Manufacturing Market Strengths and Weaknesses: CMO Perspective, 2019-2029
Table 9.2 Pharma Contract Manufacturing Market Opportunities and Threats: CMO Perspective, 2019-2029
Table 9.3 Pharma Contract Manufacturing Market: STEP Analysis, 2019-2029
Table 9.4 Selected Lyophilisation Service Providers
Table 9.5 Lyophilisation vs. Spray Drying: A Comparison
Table 9.6 Selected Biological Manufacturing Expansion, 2013-2018
Table 9.7 Selected EU-Approved Biosimilars: Manufacturers and Companies, 2018
Table 9.8 Selected CMOs Growing Faster than the Market, 2007-2012
Table 9.9 Regional Market Expansion, 2010-2017
Table 10.1 Pharma Contract Manufacturing Market Strengths and Weaknesses: Client Perspective, 2019-2029
Table 10.2 Pharma Contract Manufacturing Market Opportunities and Threats: Client Perspective, 2019-2029
Table 10.3 Benefits and Risks to Outsourcing Pharma Manufacturing
Table 10.4 ICH Guidelines: Key Facts and Adoption, 2000-2014
Table 12.1 Pharma Contract Manufacturing Market: Revenue ($bn), CAGR (%), and Market Share (%) by Sector, 2018, 2023 and 2029
Table 12.2 Pharma Contract Manufacturing Market: Revenue ($bn), CAGR (%), and Market Share (%) by Region, 2018, 2023 and 2029

List of Figures
Figure 1.1 Global Pharmaceutical Contract Manufacturing Market Segmentation Overview, 2019
Figure 2.1 Selected Services Offered by CMOs
Figure 2.2 Major Trends Affecting Pharma Contract Manufacturing Revenue Growth, 2018-2029
Figure 3.1 Pharma Contract Manufacturing: Market Share (%) by Sector, 2018
Figure 3.2 Pharmaceutical Contract Manufacturing Market: Overall Market Forecast, Revenue ($bn), 2018-2029
Figure 3.3 Pharma Contract Manufacturing Market: Shares (%), 2024
Figure 3.4 Pharma Contract Manufacturing Market: Shares (%), 2029
Figure 3.5 Pharma Contract Manufacturing Market: Drivers, 2018-2029
Figure 3.6 Pharma Contract Manufacturing Market: Restraints, 2018-2029
Figure 3.7 Other Services Submarket Forecast, Revenue ($bn), 2018-2029
Figure 4.1 Contract API Manufacturing Submarket: Segment Shares (%) by Sector, 2018
Figure 4.2 Contract API Manufacturing Submarket Forecast, Revenue ($bn), 2019-2029
Figure 4.3 Contract API Manufacturing Submarket: Segment Shares (%), 2023
Figure 4.4 Contract API Manufacturing Submarket: Segment Shares (%), 2029
Figure 4.5 Contract Generic API Manufacturing Submarket Forecast, Revenue ($bn), 2019-2029
Figure 4.6 Contract HPAPI Manufacturing Submarket Forecast, Revenue ($bn), 2018-2029
Figure 5.1 Contract FDF Manufacturing Submarket: Segment Shares (%) by Sector, 2018
Figure 5.2 Contract FDF Manufacturing Submarket Forecast, Revenue ($bn), 2019-2029
Figure 5.3 Contract FDF Manufacturing Submarket: Segment Shares (%), 2023
Figure 5.4 Contract FDF Manufacturing Submarket: Segment Shares (%), 2029
Figure 5.5 Contract Solid Dosage Manufacturing Submarket Forecast ($bn), 2019-2029
Figure 5.6 Contract Injectable Dosage Manufacturing Submarket Forecast, Revenue ($bn), 2019-2029
Figure 6.1 Pharma Contract Manufacturing Market: Share (%) by Region, 2018
Figure 6.2 Pharmaceutical Contract Manufacturing Market: Share (%) by Region, 2023
Figure 6.3 Pharmaceutical Contract Manufacturing Market: Share (%) by Region, 2029
Figure 6.4 US Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2018-2029
Figure 6.5 Canada Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2018-2029
Figure 6.6 EU5 Pharma Contract Manufacturing Market: Share (%) by Country, 2018
Figure 6.7 EU5 Pharma Contract Manufacturing Market: Share (%) by Country, 2023
Figure 6.8 EU5 Pharma Contract Manufacturing Market: Share (%) by Country, 2029
Figure 6.9 EU5 Pharma Contract Manufacturing Market, Revenue ($bn), 2018-2029
Figure 6.10 German Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2018-2029
Figure 6.11 French Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2019-2029
Figure 6.12 Italian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2018-2029
Figure 6.13 Spanish Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2019-2029
Figure 6.14 UK Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2019-2029
Figure 6.15 Japanese Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2019-2029
Figure 7.1 Pharma Contract Manufacturing Market: Emerging Market Share (%) by Top Country, 2018
Figure 7.2 Pharma Contract Manufacturing Market: Emerging Market Share (%) by Top Country, 2023
Figure 7.3 Pharma Contract Manufacturing Market: Emerging Market Share (%) by Top Country, 2029
Figure 7.4 Pharma Contract Manufacturing Market: Emerging Market Share (%) by Top Country, 2018, 2023 and 2029
Figure 7.5 Chinese Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2019-2029
Figure 7.6 Indian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2019-2029
Figure 7.7 Brazilian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2019-2029
Figure 7.8 Russian Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2019-2029
Figure 7.9 South Korean Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2019-2029
Figure 7.10 Turkey Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2019-2029
Figure 7.11 Mexico Pharma Contract Manufacturing: Market Forecast, Revenue ($bn), 2019-2029
Figure 8.1 Catalent: Revenue ($bn), 2012-2017
Figure 8.2 Lonza: Revenue (CHF bn), 2013-2018
Figure 8.3 Teva: Revenue ($bn), 2013-2018
Figure 8.4 Boehringer Ingelheim BioXcellence: Revenue ($bn), 2012-2017
Figure 10.1 Overview of Approved ICH Manufacturing Guidelines
Figure 12.1 Pharma Contract Manufacturing Market: Revenue ($bn) by Sector, 2018, 2023 and 2029
Figure 12.2 Pharma Contract Manufacturing Market: Revenue ($bn) by Region, 2018, 2023 and 2029

発刊日

2019/08/19

体裁

PDF / 231ページ

販売価格

2,699GBP

発行

Visiongain

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。
※シングルユーザーライセンスのレポートは印刷不可、およびライセンス期間は1年となります。
※印刷可能のレポートをご希望の場合は、デパートメントライセンス(ライセンス期間1年、ユーザー数5人)をご検討ください。
※詳しくはお問い合わせください。

関連カテゴリ

医薬品原料・製剤 / アウトソーシング

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE